Position in OCGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$383,001
New position
Shares Held
211,603
first reported quarter
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $423,659,922 across 151 Biotechnology names. OCGN ranks #84 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
974,776 | $55,065,096 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,001 | $24,725,252 | |
| 3 | BNTX |
BioNTech SE
|
275,000 | $24,442,000 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
295,100 | $22,159,059 | |
| 5 | ARGX |
Argenx SE
|
30,000 | $21,907,500 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,000 | $20,094,300 | |
| 7 | IMCR |
Immunocore Holdings plc
|
633,174 | $19,090,196 | |
| 8 | LEGN |
Legend Biotech Corp
|
876,351 | $15,853,189 |
All Filings in OCGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $383,001 | 211,603 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||